1. Liu K, Stern S, Heil EL, Li L, Khairi R, Heyward S, and Wang H. (2023) Dexamethasone mitigates remdesivir-induced liver toxicity in human primary hepatocytes and COVID-19 patients. Hepatol Commun. Feb; 7(3):e0034. PMID: 36809346.
  2. Men S and Wang H. (2023) Phenobarbital in nuclear receptor activation: an update. Drug Metab Dispos. Feb; 51(2):210-218. PMID: 36351837.
  3. Mackowiak B, Xu M, Lin Y, Seo W, Ren R, Feng D, Jones J, Wang H, and Gao B. (2022) Hepatic CYP2B10 is highly induced by binge ethanol and contributes to acute-on-chronic alcohol-induced liver injury. Alcohol Clin Exp Res. Dec; 46(12):2163-2176. PMID: 36224745.
  4. Metry M, Krug SA, Karra VK, Kane MA, Fink JC, Wang H, and Polli JE. (2022) Differential effects of metformin on pravastatin and bile acid pharmacokinetics in humans. Clin Transl Sci. July 28. Doi:10.1111/cts.13375. PMID: 35899436.
  5. Stern S, Liang D, Li L, Kurian R, Lynch C, Sakamuru S, Heyward S, Zhang J, Kareen A, Chun Y, Huang R, Xia M, Hong C, Xue F, and Wang H (2022) CAR/Nrf2 cooperate to improve cyclophosphamide bioactivation while reducing doxorubicin-induced cardiotoxicity in triple-negative breast cancer treatment. JCI Insight. 7(12): e153868. doi: 10.1172/jci.insight.153868, PMID: 35579950.
  6. Li Z, Kwon S, Li D, Li, L, Peng X, Zhang J, Sueyoshi T, Raufman J, Negishi M, Wang X, and Wang H (2022) Human constitutive androstane receptor represses liver cancer development and hepatoma cell proliferation by down-regulating erythropoietin signaling. J Biol Chem. 298(5): 101885. Doi: 10.1016/j.jbc.2022.101885. PMID: 35367211.
  7. Lynch C, Zhao J, Wang H, and Xia M. (2022) Identifying CAR modulators utilizing a reporter gene assay. Methods Mol. Biol. 2474: 29-38. Doi:10.1007/978-1-0716-2213-1_4. PMID: 35294753.
  8. Stern S, Kurian R, and Wang H (2022) Clinical relevance of the constitutive androstane receptor. Drug Metab Dispos. Jul;50(7):1010-1018. PMID: 35236665.
  9. Hong Z, Liu T, Wan L, Fa P, Kumar P, Prasad C, Qiu Z, Liu J, Wang H, Li Z, Wang Q, Guo D, Yilmaz A, Papandreou I, Jacob N, She Q, Yan C, Zhang X, Ma Z, and Zhang J. (2022) Targeting SQLE enhances radiotherapy by interrupting homologous recombination via the seqalene accumulation-induced ER stress response. Cancer Res. 82(7):1298-1312. PMID: 35045984.
  10. Rizzolo D, Kong B, Piekos S, Chen L, Zhong X, Lu J, Shi J, Zhu H, Yang Q, Li A, Li L, Wang H, Siemiatkowska A, Park C, Kagan L, and Guo G. (2021) Effects of overexpression of fibroblast growth factor 15/19 on hepatic drug metabolizing enzymes. Drug Metab Dispos. 50(4):468-477. PMID: 34965924.
  11. Li Z, Li L, Heyward S, Men H, Xu M, Sueyoshi T, and Wang H (2021) Phenobarbital induces SLC13A5 expression through activation of PXR but not CAR in human primary hepatocytes. Cells. 10(12):3381. Doi.org/10.3390/cells10123381. PMID: 34943889.
  12. Li Z and Wang H (2021) Molecular mechanisms of the SLC13A5 transcription. Metabolites. 11(10):706. Doi:10.3390/metabo11100706. PMID: 34677420.
  13. Andrisse S, Feng M, Wang Z, Awe O, Yu L, Zhang H, Bi S, Wang H, Li L, Heller N, Mauvais-Jarvis F, Wong G, Divall S, Segars J, Ahima R, Wolfe A, and Wu S. (2021) Androgen excess produced insulin resistance is ameliorated by deletion of hepatic androgen receptor in females. FASEB Journal. 35(10): e21921. Doi:10.1096/fj.202100961R. PMID: 34547140.
  14. Wang H, Brown PC, Chow E, Ewart L, Ferguson SS, Fitzpatrick S, Freedman BS, Guo G, Hedrich W, Heyward S, Hickman J, Isoherranen N, Li A, Liu Q, Mumenthaler S, Polli J, Proctor WR, Ribeiro A, Wang JY, Wange RL, and Huang S (2021) 3D cell culture models for drug pharmacokinetics, safety, and efficacy assessment. Clin Transl Sci. 14(5):1659-1680. PMID:33982436.
  15. Hedrich W and Wang H. (2021) Friend or foe: xenobiotic activation of Nrf2 in disease control and cardioprotection. Pharm Res. 38(2): 213-241. PMID: 33619640.
  16. Kurian R, Hedrich W, Mackowiak B, Li L, and Wang H. (2020) CITCO as an adjuvant facilitates CHOP-based lymphoma treatment in hCAR-transgenic mice. Cells. 21:9(11):2520. Doi:10.3390/cells9112520. PMID: 33233444.
  17. Li L, Wang H, and Jones JW. (2020) Sphingolipid metabolism as a marker of hepatotoxicity in drug-induced liver injury. Prostaglandins & other Lipid Mediators. 151:106484 doi: 10.1016/j.prostaglandins. PMID: 33007444.
  18. Shiffka SJ, Jones J, Li L, Farese AM, MacVittie TJ, Wang H, Swaan PW, and Kane MA (2020). Quantification of common and planar bile acids in tissues and cultured cells. J Lipid Res. 61(11):1524-1535. PMID: 32718973.
  19. Hu T, Huang W, Li Z, Kane M, Zhang L, Huang S, and Wang H (2020). Comparative proteomic analysis of SLC13A5 knockdown reveals elevated ketogenesis and enhanced cellular response to chemotherapeutic agents in HepG2 cells. Toxicol Appl Pharmacol. 402:115117. PMID: 32634519.
  20. Qiu Z, Fa P, Liu T, Prasad C, Ma D, Hong Z, Chan ER, Ma Z, Wang H, Li Z, He K, Wang Q, Williams TM, Yan C, Sizemore ST, Narla G, and Zhang J. (2020) Genome-wide pooled shRNA screening identifies PPP2R2A as a predicative biomarker for the response to ATR and CHK1 inhibitors. Cancer Res. 80(16):3305-3318. PMID: 32522823.
  21. Garzel B, Hu T, Li L, Lu Y, Heyward S, Polli J, Zhang L, Huang S, Raufman J, and Wang H. (2020) Metformin disrupts bile acid efflux by repressing bile salt export pump expression. Pharm Res. 37(2): 26. Doi: 10.1007/s11095-019-2753. PMID: 31907698.
  22. Wiemann C, Goetel M, Vardy A, Elcombe BM, Elcombe DR, Chatham LR, Wang H, Li L, Buesen R, Honarvar N, Treumann S, Marxfeld H, Groeters S, and Lake BG. (2019) Metazachlor: mode of action analysis for rat liver tumor formation and human relevance. Toxicology. 426:152282. Doi: 10.1016/j.tox. PMID: 31465819.
  23. Mackowiak B, Li L, Ziman A, Lynch C, Heyward S, Xia M, and Wang H. (2019) Automated imaging analysis identifies mosapride citrate represses gluconeogenesis through activation of the constitutive androstane receptor. Biochem Pharmacol. 168: 224-236. PMID: 31306645.
  24. Feng Y, Xie Y, Xu M, Li L, Selcer KW, Oberly PJ, Poloyac SM, Wang H, Li C, Dong F, Yu C, and Xie W. (2019) The hepatic steroid sulfatase and its inflammatory regulation dictates the hormone replacement therapy efficacy of conjugated equine estrogens (Premarin®). J Biol Chem. 294(32): 12112-12121. PMID: 31217279.
  25. Li L, Li Z, Mackowiak B, Welch M, Heyward S, Swaan PW, and Wang H. (2019) Mechanistic insights of phenobarbital-mediated activation of human but not mouse PXR. Mol. Pharmacol. 96(3): 330-344. PMID: 31436536.
  26. Garzel B, Zhang L, Huang S, and Wang H. (2019) A change in flow: looking beyond transporter inhibition in the development of drug-induced cholestasis. Curr Drug Metab. 20(8): 621-632, PMID: 31288715.
  27. Liang D, Li L, Lynch C, Xia M, Xue F, and Wang H. (2019) DL5050, A selective agonist for the human constitutive androstane receptor. ACS Med. Chem. Let. 10(7): 1039-1044, PMID: 31312405.
  28. Liang D, Li L, Lynch C, Mackowiak B, Ai Y, Yin Y, Xia M, Wang H, and Xue F. (2019) Human CAR agonist DL5016: A novel sensitizer for cyclophosphamide-based chemotherapies. Eur.  J. Med. Chem. 179: 84-99, PMID: 31247375.
  29. Lynch C, Mackowiak B, Huang R, Li L, Heyward S, Sakamuru S, Wang H, and Xia M. (2019) Identification of modulators that activate the constitutive androstane receptor from the Tox21 10K compound library. Toxicol Sci. 167(1): 282-292, PMID: 30247703.
  30. Mackowiak B, Hodge J, Stern S, and Wang H. (2018) The roles of xenobiotic receptors: beyond chemical disposition. Drug Metab Dispos. 46(9): 1361-1371, PMID: 29759961.
  31. Wolfson B, Lo PK, Yao Y, Li L, Wang H, and Zhou Q. (2018) Impact of miR-140 deficiency on non-alcoholic fatty liver disease. Mol Nutr Food Res. 62(13): e1800189, PMID: 29701903.
  32. Zaw MM, Munuhe T, Hedrich WD, Wang H, Banazadeh MH, Gadsden SA, Zhu L, and Ma R. (2018) Fabrication of a cell culture plate with a 3D printed mold and thermal analysis of PDMS-based casting process. J of Thermal Sci Eng Appl. 10: 061002-1-8.
  33. Yang X, Pan Y, Qiu Z, Du Z, Zhang Y, Fa P, Gorityala S, Ma D, Li S, Wang H, Yan C, Xu Y, Ruth K, Ma Z, and Zhang J. (2018) RNF126 as a biomarker of a poor prognosis in invasive breast cancer and CHK1 inhibitor efficacy in breast cancer cells. Clin Cancer Res. 24(7): 1629-1643. PMID: 29326282.
  34. Hedrich WD, Fandy TE, Wang H, and Hassan HE. (2018) Antibody-drug conjugates: Pharmacokinetic/Pharmacodynamic modeling, preclinical characterization, clinical studies, and lessons learned. Clin Pharmacokinet. 57(6): 687-703. PMID: 29188435.
  35. Li Z, Li D, Choi E, Lapidus R, Zhang L, Huang S, Shapiro P, and Wang H. (2017) Silencing of solute carrier family 13 member 5 disrupts energy homeostasis and inhibits proliferation of human hepatocarcinoma cells. J Biol Chem. 292(33): 13890-13901. PMID: 28655760. (Editor’s Pick, Highlighted)
  36. Mackowiak B, Li L, Li D, Jones JW, Heyward S, Kane M, Swaan P, and Wang H. (2017) Metabolism-based conversion of PK11195 from an antagonist to an agonist of human CAR in liver cells. Mol Pharmacol. 92(1): 75-87. PMID: 28442602.
  37. Zuo R, Li F, Sweta P, Cooper KL, Hong Y, Liu J, Faris RA, Li D, and Wang H. (2017) Evaluation of a novel renewable hepatic cell model for precition of clinical CYP3A4 induction using correlation based RIS approach. Drug Metab Dispos. 45(2): 198-207. PMID: 28062541.
  38. Lynch C, Zhao J, Wang H, and Xia M. (2016) Quantitative high-throughput luciferase screening in identifying CAR modulators. Methods Mol Biol. 1473: 33-42. PMID: 27518621.
  39. Fahmi OA, Einolf HJ, Ramsden D, Palamanda J, Chen L, Sinz MW, Shebley M, and Wang H. (2016) Evaluation of CYP2B6 induction and prediction of clinical DDI: Considerations from the IQ Consortium Induction Working Group. Drug Metab Dispos. 34(10): 1742-8. PMID: 27422672.
  40. Hedrich WD, Hassan HE, and Wang H. (2016) Insights into CYP2B6-mediated drug-drug interactions. Acta Pharmaceutica Sinica B. 6(5): 413-425. PMID: 27709010.
  41. Zhang L, Miao X, Wang X, Pan H, Li P, Ren H, Jia Y, Lu C, Wang H, Yuan L, and Zhang G. (2016) Antiproliferation of berberine is mediated by epigenetic modification of constitutive androstane receptor metabolic pathway in hepatoma cells. Sci Rep. 6:28116. PMID: 27311637.
  42. Jackson JP, Li L, Deibert E, Wang H, and Ferguson SS. (2016) Contextualizing hepatocyte functionality of HepaRGTM to sandwich cultures of human hepatocytes & evaluation of CAR translocation in response to phenobarbital. Drug Metab Dispos. 44(9): 1463-79. PMID: 27338863.
  43. Li L, Li D, Heyward S, and Wang H. (2016) Transcriptional regulation of CYP2B6 by hepatocyte nuclear factor 3β in in human liver cells. Plos One. 11(3): e0150587. PMID: 26930610.
  44. Mackowiak B and Wang H. (2016) Mechanisms of xenobiotic receptor activation: direct vs. indirect. Biochim Biophys Acta. 1859(9): 1130-40. PMID: 26877237.
  45. Hedrich WD, Xiao J, Heyward S, Zhang Y, Zhang J, Baer MR, Hassan HE, and Wang H. (2016) Activation of the constitutive androstane receptor increases the benefit-risk ratio of CHOP-based treatment of lymphomas. Mol Cancer Ther. 15(3): 392-401. PMID: 26823489.
  46. Wang Y, Deng O, Feng Z, Du Z, Xiong X, Lai J, Yang X, Alvarado-Kristensson M, Wang H, Taylor D, Yan C, Chen C, Ma Z, and Zhang J. (2016) RNF126 promotes homologous recombination via regulation of E2F1-mediated BRCA1 expression. Oncogene. 35(11): 1363-72. PMID: 26234677.
  47. Wang A, Yang Z, Grinchuk V, Smith A, Qin B, Lu N, Wang D, Wang H, Ramalingam TR, Wynn TA, Urban JF, Shea-Donohue T, and Zhao A. (2015) IL-25 or IL-17E protects against high-fat diet induced hepatic steatosis in mice dependent upon IL-13 activation of STAT6. J of Immunology. 195(10): 4771-80. PMID: 26423151.
  48. Li D, Mackowiak B, Mitchell M, Zhang L, Huang S, and Wang H. (2015) Genome-wide analysis of human constitutive androstane receptor transcriptome in Wild-type and knockout HepaRG cells. Biochem Pharmacol. 98(1): 190-202. PMID: 26275810.
  49. Gharavi R, Hedrich W, Wang H, and Hassan HE. (2015) Potential clinical implications of drug transporter interactions with opioids. Pharm Res. 32(8): 2477-502. PMID: 25972096.
  50. Lynch C, Zhao J, Huang R, Xiao J, Li L, Heyward S, Xia M, and Wang H. (2015) Quantitative high-throughput identification of approved drugs as modulators of human constitutive androstane receptor. Sci Rep. 5, 10405; doi: 10.1038/ srep10405. PMID: 25993555.
  51. Li L, Li H, Garzel B, Sueyoshi T, Li Q, Shu Y, Zhang J, Hu B, Heyward S, Moeller T, Xie W, Negishi M, and Wang H. (2015) The SLC13A5 gene, encoding the citrate transporter, is a novel transcriptional target of the pregnane X receptor and constitutive androstane receptor, and sensitizes drug-induced steatosis in human liver. Mol Pharmacol. 87(4): 674-82. PMID: 25628225.
  52. Yang H, and Wang H. (2014) Signaling control of the constitutive androstane receptor. Protein & Cell. 5(2): 113-123. PMID: 24474196.
  53. Zhuo W, Hu L, Lv J, Wang H, Zhou H, and Fan L. (2014) Pharmacogenomics implications of Pregnane X receptor in oncology. Can Chemother & Pharmacol. 74(2): 217-27. PMID: 24889719.
  54. Lynch C, Pan Y, Li L, Heyward S, Moeller T, Swaan P, and Wang H. (2014) Activation of human CAR inhibits gluconeogenesis without affecting lipogenesis or fatty acid synthesis. Toxicol Appl Pharmacol. 279(1): 33-42. PMID: 24878338.
  55. Garzel B, Yang H, Lynch C, Zhang L, Huang S, Polli J, and Wang H. (2014) The role of BSEP gene repression in drug-induced cholestatic injury. Drug Metab Dispos. 42(3): 318-22. PMID: 24335466.
  56. Yang H, Garzel B, Li L, Shapiro P, and Wang H. (2014) Metformin represses CAR-mediated CYP2B6 induction through affecting the CAR phosphorylation signaling. Mol Pharmacol. 85(2): 249-60. PMID: 24252946. (Selected by Faculty of 1000 Biology)
  57. Sueyoshi T, Li L, Wang H, Moore R, Kodavanti P, Lehmler H, Negishi M, and Birnbaum L. (2014) Flame retardant BDE-47 effectively activates nuclear receptor CAR in human primary hepatocytes. Toxicol Sci. 137(2): 292-302. PMID: 24218150.
  58. Hassan H, Myers A, Lee I, Mason C, Wang D, Sinz M, Wang H, and Eddington N. (2013) Induction of xenobiotic receptor, transporters and drug metabolizing enzymes by oxycodone. Drug Metab Dispos. 41(5): 1060-9. PMID: 23439660.
  59. Wang D, Li L, Yang H, Ferguson S, Baer MR, Gartenhaus RB, and Wang H. (2013) The constitutive androstane receptor is a novel therapeutic target facilitating cyclophosphamide-based treatment of hematopoietic malignancies. Blood. 121(2): 329-38. PMID: 23160467.
  60. Lynch C, Pan Y, Li L, Ferguson S, Xia M, Swaan P, and Wang H. (2013) Identification of novel activators of constitutive active/androstane receptor (CAR) from FDA-approved drugs by integrated computational and biological approaches. Pharm Res. 30(2): 489-501. PMID: 23090669.
  61. Ou Z, Shi X, Gilroy RK, Kirisci L, Romkes M, Lynch C, Wang H, Xu M, Jiang M, Ren S, Gramignoli R, Strom SC, Huang M, and Xie W. (2013) Regulation of the human hydroxysteroid sulfotransferase SULT2A1 by RORα and RORγ and its potential relevance in human liver diseases. Mol Endocrinol. 27(1): 106-15. PMID: 23211525.
  62. Li L, Sinz M, Zimmermann K, and Wang H. (2012) An IGF-1R inhibitor induces CYP3A4 expression through a PXR-independent, non-canonical CAR-related mechanism. J Pharmacol Exp Ther. 340(3): 688-97. PMID: 22171088
  63. Wang D, and Wang H. (2012) Oxazaphosphorine bioactivation and detoxification: the role of xenobiotic receptors. Acta Pharmaceutica Sinica B. 2(2): 105-115.
  64. Li Q, Peng X, Yang H, Wang H, and Shu Y. (2011) Deficiency of multidrug and toxin extrusion 1 enhances renal accumulation of paraquat and deteriorates kidney injury in mice. Mol Pharm. 8(6): 2476-83. PMID: 21991918.
  65. Wang D, Li L, Fuhrman J, Ferguson S, and Wang H. (2011) The role of CAR in oxazaphosphorine-mediated induction of DMEs in human hepatocytes. Pharm Res. 28(8): 2034-44. PMID: 21487929.
  66. Pan Y, Li L, Ekins S, Kim G, Wang H, and Swaan P. (2011) Identification of novel hPXR activators amongst prescribed drugs by integrated structure- and ligand-based virtual screening. Drug Metab Dispos. 39(2): 337-44. PMID: 21068194.
  67. Li L, Hassan H, Tolson A, Ferguson S, Eddington NE, and Wang H. (2010) Differential activation of pregnane X receptor and constitutive androstane receptor by buprenorphine in primary human hepatocytes and HepG2 cells. J Pharmacol Exp Ther. 335(3): 562-71. PMID: 20829393.
  68. Tompkins L, Li H, Li L, Lynch C, Xie Y, Nakanishi T, Ross DD, and Wang H. (2010) A novel xenobiotic responsive element regulated by AhR is involved in the induction of BCRP/ABCG2 in LS174T cells. Biochem Pharmacol. 80(11): 1754-61. PMID: 20804740.
  69. Li H, Ferguson S, and Wang H. (2010) Novel mechanisms for synergistic CYP2B6 induction between a polymorphic mutation in CYP2B6 promoter and PXR activation. Mol Pharmacol. 78(4): 704-13. PMID: 20624854.
  70. Tompkins L, Lynch C, Haidar S, Polli J, and Wang H. (2010) Effects of commonly used excipients on the expression of CYP3A4 in colon and liver cells. Pharm Res. 27(8): 1703-12. PMID: 20503067.
  71. Tolson A, and Wang H. (2010) Regulation of drug-metabolizing enzymes by xenobiotic receptors: PXR and CAR. Adv Drug Deliv Rev. 62(13): 1238-49. PMID: 20727377.
  72. Li H, and Wang H. (2010) Activation of xenobiotic receptors: driving into the nucleus. Expert Opin Drug Metab Toxicol. 6(4): 1-18. PMID: 20113149.
  73. Chen T, Tompkins L, Li L, Li H, Zheng Y, and Wang H. (2010) A single amino acid controls the functional switch of human CAR1 to the xenobiotic sensitive splicing variant CAR3. J Pharmacol Exp Ther. 332(1): 106-115. PMID: 19820207.
  74. Tolson AH, Li H, Eddington ND, and Wang H. (2009) Methadone induces the expression of hepatic drug-metabolizing enzymes through the activation of pregnane X receptor and constitutive androstane receptor. Drug Metab Dispos. 37(9): 1887-1894. PMID: 19520773.
  75. Li H, Chen T, Cottrell J, and Wang H. (2009) Nuclear translocation of Ad-hCAR: a novel tool for screening of human CAR activators in human primary hepatocyte cultures. Drug Metab Dispos. 37(5): 1098-1106. (cover story) PMID: 19196842.
  76. Li L, Stanton JD, Tolson AH, Luo Y, and Wang H. (2009) Bioactive terpenoids and flavonoids from ginkgo biloba extract induce the expression of hepatic drug-metabolizing enzymes through PXR, CAR, and AhR-mediated pathways. Pharm Res. 26(4): 872-82. PMID: 19034627.
  77. Li L, Chen T, Stanton JD, Sueyoshi T, Negishi M and Wang H. (2008) The Peripheral Benzodiazepine Receptor Ligand PK11195 is a Novel Antagonist of Human Constitutive Androstane Receptor. Mol Pharmacol. 74(2): 443-453. PMID: 18492798.
  78. Wang H, and Tompkins LM. (2008) CYP2B6: New insights into a historically overlooked cytochrome P450 isozyme. Curr Drug Metab 9(7): 598-610. PMID: 18781911.
  79. Faucette SR, Zhang TC, Moore R, Sueyoshi T, Omiecinski C, LeCluyse EL, Negishi M, and Wang H. (2007) Relative Activation of Human Pregnane X Receptor versus Constitutive Androstane Receptor Defines Distinct Classes of CYP2B6 and CYP3A4 Inducers. J Pharmacol Exp Ther. 320 (1): 72-80. PMID: 17041008.
  80. Faucette SR, Sueyoshi T, Smith C, Negishi M, LeCluyse EL, and Wang H. (2006) Differential regulation of hepatic CYP2B6 and CYP3A4 genes by constitutive androstane receptor but not pregnane X receptor. J Pharmacol Exp Ther. 317(3): 1200-9. PMID: 16513849.
  81. Noble SM, Carnahan VE, Moore LB, Luntz T, Wang H, Ittoop OR, Stimmel JB, Davis-Searles PR, Watkins RE, Wisely GB, LeCluyse EL, Tripathy A, McDonnell DP, and Redinbo MR. (2006) Human PXR forms a trytophan Zipper-mediated Homodimer. Biochemistry. 45(28): 8579-8589. PMID: 16834332
  82. Smith C, Graham RA, Krol WL, Silver IS, Negishi M, Wang H, and LeCluyse EL. (2005) Differential UGT1A1 induction by chrysin in primary human hepatocytes and HepG2 cells. J Pharmacol Exp Ther. 315:1256-1264. PMID: 16135700
  83. Smith C, Faucette SR, Wang H, and LeCluyse EL. (2005) Modulation of UDP-glucuronosyltransferase 1A1 in primary human hepatocytes by prototypical inducers. J Biochem & Mol Tox. 19 (2): 96-108. PMID: 15849716
  84. Hempel N, Wang H, LeCluyse EL, McManus ME, and Negishi M. (2004) The human sulfotransferase SULT1A1 gene is regulated in a synergistic manner by Sp1 and GA Binding Protein (GABP). Mol Pharmacol. 66 (6): 1690-701. PMID: 15383623
  85. Wang H, Faucette SR, Moore R, Sueyoshi T, Negishi M, and LeCluyse EL. (2004) Human CAR mediates induction of CYP2B6 gene expression by phenytoin. J Biol Chem. 279 (28): 29295-29301. PMID: 15123723.
  86. Faucette, SR, Wang H, Hamilton G, Gilbert D, Jolley S, Lindley C, and LeCluyse EL. (2004) Regulation of CYP2B6 expression in primary human hepatocytes by prototypical inducers. Drug Metab Dispos. 32 (3): 348-358. PMID: 14977870
  87. Wang H, Faucette SR, Sueyoshi T, Moore R, Ferguson S, Negishi M, and LeCluyse EL. (2003) A novel distal enhancer module regulated by PXR/CAR is essential for the maximal induction of CYP2B6 gene expression. J Biol Chem. 278 (16): 14146-52. PMID: 12571232.
  88. Wang H, and Negishi M. (2003) Transcriptional regulation of cytochrome P450 2B genes by nuclear receptors. Curr Drug Metab. 4 (6): 515-25. PMID: 14683479. PMID: 14683479.
  89. Wang H, and LeCluyse EL. (2003) The role of orphan nuclear receptors on the regulation of drug metabolism enzymes. Clin Pharmacokinet. 42 (15): 1331-1357. 14674787. PMID: 14674787.
  90. Wang H, Faucette SR, Gilbert D, Jolley SL, Sueyoshi T, Negishi M, and LeCluyse EL. (2003) Glucocorticoids enhance PXR regulated CYP2B6 expression in primary human hepatocytes. Drug Metab Dispos. 31 (5): 620-30. PMID: 12695351.
  91. Sahi J, Milad MA, Zheng X, Rose KA, Wang H, Stilgenbauer L, Gilbert D, Jolley S, Stern RH, and LeCluyse EL. (2003) Avasimibe induces CYP3A4 and MDR1 gene expression through activation of the pregnane X receptor. J Pharmacol Exp Ther. 306: 1027-1034. PMID: 12766253.
  92. Chanas B, Wang H, Ghanayem BI. (2003) Gender differences in the metabolism of acrylonitrile to cyanide in mice: Role of cytochrome P450 2E1 and epoxide hydrolase. Toxicol Appl Pharmacol. 193(2): 293-302. PMID: 14644629
  93. Wang H, Chanas B, and Ghanayem BI. (2002) Cytochrome P450 2E1 (CYP2E1) is the only enzyme responsible for acrylonitrile metabolism to cyanide: comparative studies using CYP2E1-null and wild-type mice. Drug Metab Dispos. 30: 911-917. PMID: 12124309.
  94. Wang H, Chanas B, and Ghanayem BI. (2002) Effect of methacrylonitrile on cytochrome P-450 2E1 (CYP2E1) expression in male F344 rats. J Toxicol Env Health (Part A) 65: 523-537. PMID: 11939710.
  95. Lindley C, Hamilton G, Mccune JS, Faucette SR, Shord SS, Hawke RL, Wang H, and LeCluyse EL. (2002) The effect of cyclophosphamide with and without dexamethasone on CYP3A4 and 2B6 in human hepatocytes. Drug Metab Dispos. 30: 814-821. PMID: 12065440.
  96. Ghanayem BI, Wang H, and Sumner S. (2000) Using cytochrome P-450 gene knock-out mice to study chemical metabolism, toxicity, and carcinogenicity. Toxicol Pathol. 28(6): 839-850. PMID: 11127301